Trademark: 98304980
Word
OCELLOS
Status
Pending
Status Code
630
Status Date
Tuesday, December 12, 2023
Serial Number
98304980
Mark Type
4000
Filing Date
Friday, December 8, 2023

Trademark Owner History

Classifications
41 (Based on Intent to Use) Arranging and conducting of training courses in the field of cell and gene therapy; Arranging and conducting of training workshops in the field of operation and development of software systems; Arranging and conducting of training workshops in the field of cell and gene therapy; Training services in the field of cell and gene therapy(Based on 44(d) Priority Application) Arranging and conducting of training courses in the field of cell and gene therapy; Arranging and conducting of training workshops in the field of operation and development of software systems; Arranging and conducting of training workshops in the field of cell and gene therapy; Training services in the field of cell and gene therapy
9 (Based on Intent to Use) Downloadable computer software platforms for health data storage; Downloadable database management software for the purposes of recording, reporting, storage and processing of data; Downloadable software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Downloadable software for use in managing data for clinical trials; Downloadable software for chain of identity and chain of custody management; Downloadable software for use in therapy development; Downloadable software for analysis and reporting using artificial intelligence; Downloadable software for the provision of healthcare using artificial intelligence; Downloadable software for cell and gene therapy orchestration; Downloadable software for scheduling and planning pharmaceutical resources; Downloadable software for control and tracking of cell and gene therapy products; Downloadable software for deep learning(Based on 44(d) Priority Application) Downloadable computer software platforms for health data storage; Downloadable database management software for the purposes of recording, reporting, storage and processing of data; Downloadable software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Downloadable software for use in managing data for clinical trials; Downloadable software for chain of identity and chain of custody management; Downloadable software for use in therapy development; Downloadable software for analysis and reporting using artificial intelligence; Downloadable software for the provision of healthcare using artificial intelligence; Downloadable software for cell and gene therapy orchestration; Downloadable software for scheduling and planning pharmaceutical resources; Downloadable software for control and tracking of cell and gene therapy products; Downloadable software for deep learning
35 (Based on Intent to Use) Business data analysis; Data processing services; Database management services; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare(Based on 44(d) Priority Application) Business data analysis; Data processing services; Database management services; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare
45 (Based on Intent to Use) Licensing of intellectual property in the field of cell and gene therapy; Software licensing; Granting of software licences(Based on 44(d) Priority Application) Licensing of intellectual property in the field of cell and gene therapy; Software licensing; Granting of software licences
42 (Based on Intent to Use) Platform as a service (PAAS) featuring computer software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Platform as a service (PAAS) featuring computer software platforms for use in managing data for clinical trials; Platform as a service (PAAS) featuring computer software platforms for chain of identity and chain of custody management; Platform as a service (PAAS) featuring computer software platforms for the purposes of recording, reporting, storage and processing of data; Platform as a service (PAAS) featuring computer software platforms for use in therapy development; Platform as a service (PAAS) featuring computer software platforms for analysis and reporting using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for the provision of healthcare using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for cell and gene therapy orchestration; Platform as a service (PAAS) featuring computer software platforms for scheduling and planning pharmaceutical resources; Platform as a service (PAAS) featuring computer software platforms for health data storage; Platform as a service (PAAS) featuring computer software platforms for control and tracking of cell and gene therapy products; Platform as a service (PAAS) featuring computer software platforms for deep learning; Platform as a service (PAAS) featuring computer software platforms for database management for the purposes of recording, reporting, storage and processing of data; Software as a service (SAAS) services featuring software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Software as a service (SAAS) services featuring software for use in managing data for clinical trials; Software as a service (SAAS) services featuring software for chain of identity and chain of custody management; Software as a service (SAAS) services featuring software for use in therapy development; Software as a service (SAAS) services featuring software for analysis and reporting using artificial intelligence; Software as a service (SAAS) services featuring software for the provision of healthcare using artificial intelligence; Software as a service (SAAS) services featuring software for for cell and gene therapy orchestration; Software as a service (SAAS) services featuring software for scheduling and planning pharmaceutical resources; Software as a service (SAAS) services featuring software for control and tracking of cell and gene therapy products; Software as a service (SAAS) services featuring software for deep learning; Software as a service (SAAS) services featuring software for database management for the purposes of recording, reporting, storage and processing of data; Software as a service (SAAS) services featuring software for health data storage; Consulting services in the field of software as a service (SAAS); Computer software development; Customizing computer software; Design and development of software and hardware for data storage systems for data input, output, processing, display and storage; Design, development, and implementation of software for operating systems; Electronic data storage; Electronic storage services for archiving electronic data; Maintenance of computer software; Providing temporary use of non-downloadable cloud-based software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Providing temporary use of non-downloadable cloud-based software for use in managing data for clinical trials; Providing temporary use of non-downloadable cloud-based software for chain of identity and chain of custody management; Providing temporary use of non-downloadable cloud-based software for use in therapy development; Providing temporary use of non-downloadable cloud-based software for analysis and reporting using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for the provision of healthcare using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for cell and gene therapy orchestration; Providing temporary use of non-downloadable cloud-based software for scheduling and planning pharmaceutical resources; Providing temporary use of non-downloadable cloud-based software for control and tracking of cell and gene therapy products; Providing temporary use of non-downloadable cloud-based software for deep learning; Providing temporary use of non-downloadable cloud-based software for database management for the purposes of recording, reporting, storage and processing of data; Providing temporary use of non-downloadable cloud-based software for health data storage(Based on 44(d) Priority Application) Platform as a service (PAAS) featuring computer software platforms for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Platform as a service (PAAS) featuring computer software platforms for use in managing data for clinical trials; Platform as a service (PAAS) featuring computer software platforms for chain of identity and chain of custody management; Platform as a service (PAAS) featuring computer software platforms for the purposes of recording, reporting, storage and processing of data; Platform as a service (PAAS) featuring computer software platforms for use in therapy development; Platform as a service (PAAS) featuring computer software platforms for analysis and reporting using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for the provision of healthcare using artificial intelligence; Platform as a service (PAAS) featuring computer software platforms for cell and gene therapy orchestration; Platform as a service (PAAS) featuring computer software platforms for scheduling and planning pharmaceutical resources; Platform as a service (PAAS) featuring computer software platforms for health data storage; Platform as a service (PAAS) featuring computer software platforms for control and tracking of cell and gene therapy products; Platform as a service (PAAS) featuring computer software platforms for deep learning; Platform as a service (PAAS) featuring computer software platforms for database management for the purposes of recording, reporting, storage and processing of data; Software as a service (SAAS) services featuring software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Software as a service (SAAS) services featuring software for use in managing data for clinical trials; Software as a service (SAAS) services featuring software for chain of identity and chain of custody management; Software as a service (SAAS) services featuring software for use in therapy development; Software as a service (SAAS) services featuring software for analysis and reporting using artificial intelligence; Software as a service (SAAS) services featuring software for the provision of healthcare using artificial intelligence; Software as a service (SAAS) services featuring software for for cell and gene therapy orchestration; Software as a service (SAAS) services featuring software for scheduling and planning pharmaceutical resources; Software as a service (SAAS) services featuring software for control and tracking of cell and gene therapy products; Software as a service (SAAS) services featuring software for deep learning; Software as a service (SAAS) services featuring software for database management for the purposes of recording, reporting, storage and processing of data; Software as a service (SAAS) services featuring software for health data storage; Consulting services in the field of software as a service (SAAS); Computer software development; Customizing computer software; Design and development of software and hardware for data storage systems for data input, output, processing, display and storage; Design, development, and implementation of software for operating systems; Electronic data storage; Electronic storage services for archiving electronic data; Maintenance of computer software; Providing temporary use of non-downloadable cloud-based software for use and integration in supply chain management related to cell and gene therapy and advanced therapies; Providing temporary use of non-downloadable cloud-based software for use in managing data for clinical trials; Providing temporary use of non-downloadable cloud-based software for chain of identity and chain of custody management; Providing temporary use of non-downloadable cloud-based software for use in therapy development; Providing temporary use of non-downloadable cloud-based software for analysis and reporting using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for the provision of healthcare using artificial intelligence; Providing temporary use of non-downloadable cloud-based software for cell and gene therapy orchestration; Providing temporary use of non-downloadable cloud-based software for scheduling and planning pharmaceutical resources; Providing temporary use of non-downloadable cloud-based software for control and tracking of cell and gene therapy products; Providing temporary use of non-downloadable cloud-based software for deep learning; Providing temporary use of non-downloadable cloud-based software for database management for the purposes of recording, reporting, storage and processing of data; Providing temporary use of non-downloadable cloud-based software for health data storage

Trademark Events
Jan 25, 2024
New Application Office Supplied Data Entered
Dec 12, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24